Abstract

The present invention relates to a composition for topical administration comprising a colloidal oatmeal and a 4-t-butylcyclohexanol, wherein the colloidal oatmeal comprises β-glucan and optionally avenanthramide. The 4-t-butylcyclohexanol is in an amount in the range of 0.1-5 wt % of the total amount of the composition, and the β-glucan is in an amount in the range of 1-10 wt % of the total amount of the composition. The present invention further relates to said composition for topical administration for use in therapy and said composition for topical administration for use in treating or preventing a skin condition associated with cancer radiation therapy or chemotherapy, and also the use of said composition in treating or preventing a skin condition associated with cancer radiation therapy or chemotherapy.

IPC Classes  ?

• A61K 31/045 - Hydroxy compounds, e.g. alcoholsSalts thereof, e.g. alcoholates
• A61K 9/00 - Medicinal preparations characterised by special physical form
• A61K 31/716 - Glucans
• A61K 36/185 - Magnoliopsida (dicotyledons)
• A61K 36/886 - Aloeaceae (Aloe family), e.g. aloe vera
• A61P 17/02 - Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
• A61P 17/16 - Emollients or protectives, e.g. against radiation

IPC Classes  ?

• A61K 8/18 - Cosmetics or similar toiletry preparations characterised by the composition
• A61K 8/34 - Alcohols
• A61K 8/73 - Polysaccharides
• A61K 31/716 - Glucans
• A61K 131/00 - Containing or obtained from seeds, nuts, fruits or grains
• A61P 17/02 - Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
• A61P 17/16 - Emollients or protectives, e.g. against radiation

Abstract

The present invention relates to a composition for topical administration comprising a colloidal oatmeal and a 4-t-butylcyclohexanol, wherein the colloidal oatmeal comprises β- glucan and optionally avenanthramide. The 4-t-butylcyclohexanol is in an amount in the range of 0.1-5 wt % of the total amount of the composition, and the β-glucan is in an amount in the range of 1-10 wt % of the total amount of the composition. The present invention further relates to said composition for topical administration for use in therapy and said composition for topical administration for use in treating or preventing a skin condition associated with cancer radiation therapy or chemotherapy, and also the use of said composition in treating or preventing a skin condition associated with cancer radiation therapy or chemotherapy.

IPC Classes  ?

• A61K 8/18 - Cosmetics or similar toiletry preparations characterised by the composition
• A61K 8/34 - Alcohols
• A61K 8/73 - Polysaccharides
• A61K 31/716 - Glucans
• A61P 17/00 - Drugs for dermatological disorders
• A61P 17/02 - Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
• A61P 17/16 - Emollients or protectives, e.g. against radiation
• A61K 131/00 - Containing or obtained from seeds, nuts, fruits or grains